Journal article 683 views
The Transcription Factor STAT-1 Couples Macrophage Synthesis of 25-Hydroxycholesterol to the Interferon Antiviral Response / Mathieu Blanc, Wei Yuan Hsieh, Kevin A Robertson, Kai A Kropp, Thorsten Forster, Guanghou Shui, Paul Lacaze, Steven Watterson, Samantha J Griffiths, Nathanael J Spann, Anna Meljon, Simon Talbot, Kathiresan Krishnan, Douglas F Covey, Markus R Wenk, Marie Craigon, Zsolts Ruzsics, Jürgen Haas, Ana Angulo, William J Griffiths, Christopher K Glass, Yuqin Wang, Peter Ghazal, William Griffiths
Immunity, Volume: 38, Issue: 1, Pages: 106 - 118
Full text not available from this repository: check for access using links below.
Recent studies suggest that the sterol metabolic network participates in the interferon (IFN) antiviral response. However, the molecular mechanisms linking IFN with the sterol network and the identity of sterol mediators remain unknown. Here we report a cellular antiviral role for macrophage product...
Check full text
No Tags, Be the first to tag this record!
Recent studies suggest that the sterol metabolic network participates in the interferon (IFN) antiviral response. However, the molecular mechanisms linking IFN with the sterol network and the identity of sterol mediators remain unknown. Here we report a cellular antiviral role for macrophage production of 25-hydroxycholesterol (cholest-5-en-3β,25-diol, 25HC) as a component of the sterol metabolic network linked to the IFN response via Stat1. By utilizing quantitative metabolome profiling of all naturally occurring oxysterols upon infection or IFN-stimulation, we reveal 25HC as the only macrophage-synthesized and -secreted oxysterol. We show that 25HC can act at multiple levels as a potent paracrine inhibitor of viral infection for a broad range of viruses. We also demonstrate, using transcriptional regulatory-network analyses, genetic interventions and chromatin immunoprecipitation experiments that Stat1 directly coupled Ch25h regulation to IFN in macrophages. Our studies describe a physiological role for 25HC as a sterol-lipid effector of an innate immune pathway.
Swansea University Medical School